Energy coach tool – managing cancer related fatigue
Register and join the Leukaemia Foundation’s blood cancer online support service for free to access the energy coach to help manage cancer related fatigue.
Why access the digital energy coach?
- At least 6 in 10 people diagnosed with cancer report suffering from cancer related fatigue (CRF)
- CRF is a side-effect that has an enormous impact on quality of life
- managing CRF effectively can be life changing
What is a digital energy coach?
The energy coach enables members
- to record their daily energy levels each day over a week
- to recognise what affects their energy levels over seven days
- to see patterns, trends, and recommendations via evidence-based strategies
The Energy Coach is used to
- identify energy levels
- discover ways of managing fatigue
- provide tailored strategies to help with fatigue
Patient tip:
“I also love that the 3 selected tips/strategies are integrated back into the ‘My Dashboard’ section“
You will rate your:
- sleep
- diet
- exercise
- energy levels
and see how they all connect to your fatigue levels. We want to help you get back to doing the things you love.
Patient quote after using the energy coach:
“Love the energy coach! As promised, I completed the 7-day review and I think it’s a fantastic resource, with useful insights and fatigue management tips“
The energy coach is a 7 day program to help you understand and manage your cancer related fatigue.
Learn more
Need help?
Blood cancers A-Z
We’re here for anyone with any blood cancer, every step of the way.
A
Acute lymphoblastic leukaemia (ALL)
Acute myeloid leukaemia (AML)
Acute promyelocytic leukaemia (APML)
Adult T-cell lymphoma
AL amyloidosis
Amyloidosis
Anaplastic large cell lymphoma
Aplastic anaemia
B
Biphenotypic leukaemia
Burkitt’s lymphoma
C
Childhood acute lymphoblastic leukaemia (ALL)
Childhood acute myeloid leukaemia (AML)
Childhood blood cancers
Childhood lymphoma
Childhood MDS and MPN
Chronic lymphocytic leukaemia (CLL)
Chronic myeloid leukaemia (CML)
Chronic myelomonocytic leukaemia (CMML)
Cutaneous lymphomas
D
E
Essential thrombocythaemia (ET)
F
H
Hairy cell leukaemia (HCL)
Hodgkin lymphoma (HL)
J
Juvenile myelomonocytic leukaemia (JMML)
L
M
Mucosa-associated lymphoid tissue lymphoma (MALT)
Mantle cell lymphoma (MCL)
Marginal zone lymphoma (MZL)
Monoclonal gammopathy of unknown significance (MGUS)
Myelodysplastic neoplasms (MDS)
Myeloma
Myeloproliferative neoplasms (MPN)
N
P
Peripheral T-cell lymphoma
Polycythaemia (rubra) vera
Primary central nervous system lymphoma
Primary myelofibrosis
S
Skin (cutaneous) lymphomas
Small lymphocytic lymphoma (SLL)